PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
SANA vs. CABA
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Performance

SANA vs. CABA - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Sana Biotechnology, Inc. (SANA) and Cabaletta Bio, Inc. (CABA). The values are adjusted to include any dividend payments, if applicable.

-80.00%-60.00%-40.00%-20.00%0.00%20.00%JuneJulyAugustSeptemberOctoberNovember
-67.44%
-82.88%
SANA
CABA

Returns By Period

In the year-to-date period, SANA achieves a -36.03% return, which is significantly higher than CABA's -91.76% return.


SANA

YTD

-36.03%

1M

-31.13%

6M

-67.46%

1Y

-38.59%

5Y (annualized)

N/A

10Y (annualized)

N/A

CABA

YTD

-91.76%

1M

-53.60%

6M

-82.88%

1Y

-89.86%

5Y (annualized)

-32.45%

10Y (annualized)

N/A

Fundamentals


SANACABA
Market Cap$564.87M$91.40M
EPS-$1.40-$2.16
Total Revenue (TTM)$0.00$4.01M
Gross Profit (TTM)-$15.18M$2.86M
EBITDA (TTM)-$288.41M-$113.35M

Key characteristics


SANACABA
Sharpe Ratio-0.41-0.94
Sortino Ratio-0.11-2.32
Omega Ratio0.990.71
Calmar Ratio-0.41-0.97
Martin Ratio-0.91-1.54
Ulcer Index42.23%58.34%
Daily Std Dev93.42%96.08%
Max Drawdown-94.62%-96.63%
Current Drawdown-94.00%-92.63%

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Correlation

-0.50.00.51.00.3

The correlation between SANA and CABA is 0.34, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Risk-Adjusted Performance

SANA vs. CABA - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Sana Biotechnology, Inc. (SANA) and Cabaletta Bio, Inc. (CABA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for SANA, currently valued at -0.41, compared to the broader market-4.00-2.000.002.004.00-0.41-0.94
The chart of Sortino ratio for SANA, currently valued at -0.11, compared to the broader market-4.00-2.000.002.004.00-0.11-2.32
The chart of Omega ratio for SANA, currently valued at 0.99, compared to the broader market0.501.001.502.000.990.71
The chart of Calmar ratio for SANA, currently valued at -0.41, compared to the broader market0.002.004.006.00-0.41-0.97
The chart of Martin ratio for SANA, currently valued at -0.91, compared to the broader market0.0010.0020.0030.00-0.91-1.54
SANA
CABA

The current SANA Sharpe Ratio is -0.41, which is higher than the CABA Sharpe Ratio of -0.94. The chart below compares the historical Sharpe Ratios of SANA and CABA, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Rolling 12-month Sharpe Ratio-1.00-0.80-0.60-0.40-0.200.000.200.40JuneJulyAugustSeptemberOctoberNovember
-0.41
-0.94
SANA
CABA

Dividends

SANA vs. CABA - Dividend Comparison

Neither SANA nor CABA has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

SANA vs. CABA - Drawdown Comparison

The maximum SANA drawdown since its inception was -94.62%, roughly equal to the maximum CABA drawdown of -96.63%. Use the drawdown chart below to compare losses from any high point for SANA and CABA. For additional features, visit the drawdowns tool.


-90.00%-80.00%-70.00%-60.00%-50.00%JuneJulyAugustSeptemberOctoberNovember
-94.00%
-92.63%
SANA
CABA

Volatility

SANA vs. CABA - Volatility Comparison

The current volatility for Sana Biotechnology, Inc. (SANA) is 24.45%, while Cabaletta Bio, Inc. (CABA) has a volatility of 38.22%. This indicates that SANA experiences smaller price fluctuations and is considered to be less risky than CABA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


10.00%20.00%30.00%40.00%50.00%JuneJulyAugustSeptemberOctoberNovember
24.45%
38.22%
SANA
CABA

Financials

SANA vs. CABA - Financials Comparison

This section allows you to compare key financial metrics between Sana Biotechnology, Inc. and Cabaletta Bio, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items